Why the study?
Does ST-segment elevation in lead aVR predict a high SYNTAX score in patients with NSTEACS?
Does ST-segment elevation in lead aVR predict a high SYNTAX score in patients with NSTEACS?
In patients with NSTEACS, ST-segment elevation in lead aVR is an independent predictor of a high SYNTAX score and left main or three-vessel disease.
No correlation between STEaVR and SYNTAX score in ACS; leaves open whether STEaVR refines angiographic risk stratification beyond LM/3VD.
BACKGROUND: ST-segment elevation in lead aVR (STEaVR) anticipates left main and/or three-vessel disease (LM/3VD) in patients with acute coronary syndromes. STEaVR is generally reciprocal to and accompanied by ST-segment depression (STD) in the precordial leads. SYNTAX score (SS) is an angiographic scoring system and is widely used to evaluate the severity and complexity of coronary artery disease. The purpose of our study was to assess the relationship between STEaVR and SS. METHODS: We performed a retrospective analysis of 117 patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Electrocardiograms at presentation were reviewed, especially for ST-segment elevation of ≥ 0.05 mV in lead aVR and STD of ≥ 0.05 mV in more than two contiguous leads. All lesions causing ≥ 50% stenosis in a coronary artery with a diameter of ≥ 1.5 mm were included in the SS calculation. SS was divided into two groups: ≥ 23: high, < 23: low. RESULTS: (OR 2.14; 95% CI: 1.46-4.23, p = 0.002) were independent predictors of a high SS. CONCLUSION: This study demonstrated that STEaVR was an independent predictor of a high SS.
No takes yet. Share an insight, caveat, or question.
Levent Ceri̇t (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: